The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David KatzensteinStudy Chair
- Mary AlbrechtStudy Chair
- Scott HammerStudy Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Puerto Rico-Aids Crs
San Juan, Puerto Rico
- Cook County Hosp. Core Ctr.
Chicago, Illinois, United States
- Northwestern University Crs
Chicago, Illinois, United States
- Rush Univ. Med. Ctr. Actg Crs
Chicago, Illinois, United States
- Johns Hopkins Adult Aids Crs
Baltimore, Maryland, United States
- Ny Univ. Hiv/aids Crs
New York, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- 31 Jul 2000
- Last update posted
- 1 Nov 2021
- Registered enrollment
- 300
- Registry id
- NCT00001087
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.